Skip to main content

Peer Review reports

From: A phase I study comparing the biosimilarity of the pharmacokinetics and safety of recombinant humanized anti-vascular endothelial growth factor monoclonal antibody injection with Avastin® in healthy Chinese male subjects

Original Submission
5 Sep 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
17 Jan 2023 Reviewed Reviewer Report
23 Jan 2023 Reviewed Reviewer Report
20 Feb 2023 Author responded Author comments - Yunqiu Xie
Resubmission - Version 4
20 Feb 2023 Submitted Manuscript version 4
13 Apr 2023 Reviewed Reviewer Report
13 Apr 2023 Reviewed Reviewer Report
2 May 2023 Author responded Author comments - Yunqiu Xie
Resubmission - Version 5
2 May 2023 Submitted Manuscript version 5
Publishing
9 May 2023 Editorially accepted
27 May 2023 Article published 10.1186/s40360-023-00673-y

You can find further information about peer review here.

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us